Ministry of Health of Colombia nominates 10 technologies and services to the “list of exclusions”.

The Ministry considers that none of them has enough evidence of efficacy and safety, and therefore should not be paid with public resources allocated to health: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VP/RBC/nominaciones-primera-semana-resolucion-330-2017.pdf

1. Theophyline
2. Anakinra
3. Diazepam for the treatment of eclampsia
4. Phenytoin for the treatment of eclampsia
5. Breast reconstruction with prosthesis before postmastectomy radiotherapy
6. Therapeutic shades for the treatment of autism
7. Therapies that are not part of the ABA therapeutic approach for the treatment of autism
8. Dexrazoxane in pediatric population as cardioprotector in patients treated with doxorubicin and epirubicin
9. Irinotecan for pediatric use in colon, ovary, bronchial or lung cancer
10. Octreotide in neonates and infants